Guardian Pharmacy Services (GRDN) Asset Writedowns and Impairment (2023 - 2026)

Guardian Pharmacy Services has disclosed Asset Writedowns and Impairment across 4 years of filings, most recently posting $1.1 million for Q1 2026.

• Asset Writedowns and Impairment for Q1 2026 came in at $1.1 million, up 18.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.7 million (down 19.14% YoY), and the FY2025 annual result was $4.6 million, down 28.08% from the prior year.
• Asset Writedowns and Impairment came in at $1.1 million for Q1 2026 at Guardian Pharmacy Services, down from $1.5 million in the prior quarter.
• In the past five years, Asset Writedowns and Impairment ranged from a high of $2.1 million in Q4 2024 to a low of $896000.0 in Q1 2025.
• The 4-year median for Asset Writedowns and Impairment is $1.3 million (2023), against an average of $1.3 million.
• Across the five-year window, Asset Writedowns and Impairment soared 56.27% in 2024 and sank 42.0% in 2025, its largest moves.
• Guardian Pharmacy Services' Asset Writedowns and Impairment stood at $1.4 million in 2023, then jumped by 56.27% to $2.1 million in 2024, then plunged by 30.94% to $1.5 million in 2025, then slipped by 27.8% to $1.1 million in 2026.
• The last three Asset Writedowns and Impairment figures came in at $1.1 million (Q1 2026), $1.5 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.